The current price of STRO is USD — it has decreased by −% in the past 24 hours. Watch Sutro Biopharma, Inc. stock price performance more closely on. Sutro Biopharma Stock (NASDAQ: STRO) stock price, news, charts, stock research, profile. On average, Wall Street analysts predict that Sutro Biopharma's share price could reach $ by Aug 16, The average Sutro Biopharma stock price. See the latest Sutro Biopharma Inc stock price (STRO:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Sutro Biopharma (STRO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend.
Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics. Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rate of rising. We conclude that the. STRO | Complete Sutro Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. Discover real-time Sutro Biopharma, Inc. Common Stock (STRO) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Stock Data · SEC Filings · Governance · News · News Releases · Presentation Stock Data. Quote and Chart · Historical Data · Analyst Coverage. Settings. Stock analysis for Sutro Biopharma Inc (STRO:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Track Sutro Biopharma Inc (STRO) Stock Price, Quote, latest community messages, chart, news and other stock related information. On Monday morning 08/26/ the Sutro Biopharma Inc Registered Shs share started trading at the price of $ Sutro Biopharma Inc (STRO) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.
Stock Data ; Bank of America, Tazeen Ahmad ; Cowen, Tara Bancroft ; Deutsche Bank, James Shin ; H.C. Wainwright, Andrew S. Fein. Stock Data. Quote and Chart · Historical Data · Analyst Coverage. Chart. Sutro Biopharma Inc. NASDAQ Global Market: STRO. Events. Earnings. Dividends. Splits. Sutro Biopharma Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Based on short-term price targets offered by 10 analysts, the average price target for Sutro Biopharma, Inc. comes to $ The forecasts range from a low of. Sutro Biopharma Inc STRO:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date03/28/24 · 52 Week Low · Find annual and quearterly earnings data for Sutro Biopharma, Inc. Common Stock (STRO) including earnings per share, earnings forecasts at pr46.ru The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics. Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and.
Research Sutro Biopharma's (Nasdaq:STRO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. NASDAQ: STRO. Stock Symbol. News and Events · Financial Results · Stock Data. Press Releases. Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial. STRO's current price target is $ Learn why top analysts are making this stock forecast for Sutro Biopharma at MarketBeat. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. STRO will report STRO Sutro Biopharma · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. M · Turnover Ratio. % · P/E (Static). Loss.
Sutro Biopharma Inc's trailing month revenue is $ million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Sutro Biopharma Inc is currently in a favorable trading position (BUY) according to technical analysis indicators. More on Technical Analysis. Peers. Sutro Biopharma ; Will Biopharma Companies Shun Vaccine R&D In A New Pandemic? · ByJohn LaMattinaContributor ; InnovationRx: Biopharma VCs Placed Fewer But Surer. Sutro Biopharma (STRO) USD ; Trade low · $ ; Year low · $ ; Previous · $ ; Volume · n/a ; Dividend yield · %.
William Morris Talent Agent | I Need My Credit Score To Go Up